Ws Management Lllp Editas Medicine, Inc. Transaction History

Ws Management Lllp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$39.71 - $90.58 $58,214 - $132,790	-1,466 Reduced 4.84%	28,797 $1.21 Million
Q2 2020 Aug 13, 2020	SELL	$18.5 - $34.34 $96,403 - $178,945	-5,211 Reduced 14.69%	30,263 $895,000
Q1 2020 May 13, 2020	SELL	$14.88 - $32.78 $26,560 - $58,512	-1,785 Reduced 4.79%	35,474 $703,000
Q3 2019 Nov 13, 2019	SELL	$22.49 - $26.81 $92,501 - $110,269	-4,113 Reduced 9.94%	37,259 $847,000
Q2 2019 Aug 13, 2019	SELL	$20.48 - $27.76 $100,311 - $135,968	-4,898 Reduced 10.59%	41,372 $1.02 Million
Q1 2019 May 13, 2019	SELL	$19.43 - $26.41 $121,320 - $164,904	-6,244 Reduced 11.89%	46,270 $1.13 Million
Q4 2018 Feb 12, 2019	SELL	$18.19 - $31.79 $623,025 - $1.09 Million	-34,251 Reduced 39.48%	52,514 $1.2 Million
Q2 2018 Aug 13, 2018	BUY	$31.4 - $41.01 $2.72 Million - $3.56 Million	86,765 New	86,765 $3.11 Million

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.